BGLC earnings
BioNexus Gene Lab (BGLC) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- BGLC beat EPS estimates in 0 of its last 0 reports.
BGLC earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 19, 2026 | -0.39 | – | – | $47.92K |
| Q2 2026 | Aug 14, 2026 | -0.12 | – | – | $76.16K |
| Q1 2026 | May 15, 2026 | -0.23 | – | – | $22.84K |
| Q1 2026 | Apr 14, 2026 | -0.53 | – | – | $22.84K |
| Q3 2025 | Nov 14, 2025 | -0.39 | – | – | $2.54M |
| Q2 2025 | Aug 18, 2025 | -0.34 | – | – | $2.26M |
| Q1 2025 | May 15, 2025 | -0.03 | – | – | $2.14M |
| Q3 2024 | Nov 15, 2024 | -0.20 | – | – | $2.63M |
| Q2 2024 | Aug 14, 2024 | 0.10 | – | – | $1.97M |
| Q1 2024 | May 15, 2024 | -0.18 | – | – | $2.38M |
| Q3 2023 | Nov 20, 2023 | -0.20 | – | – | $2.55M |
| Q2 2023 | Aug 16, 2023 | -0.02 | – | – | $2.57M |